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rescue therapy in refractory COVID-19 ARDS. In addition, an
adequate higher level of therapeutic anticoagulation than usual
should probably be considered. n
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chez le patient hospitalisé avec le COVID-19 et surveillance de




9. Wichmann D, Sperhake JP, Lutgehetmann M, Steurer S, Edler C,
Heinemann A, et al. Autopsy findings and venous thromboembolism in
patients with COVID-19: a prospective cohort study. Ann Intern Med
[online ahead of print] 6 May 2020; DOI: 10.7326/M20-2003.
10. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M,
Delabranche X, et al.; CRICS TRIGGERSEP Group (Clinical Research
in Intensive Care and Sepsis Trial Group for Global Evaluation and
Research in Sepsis). High risk of thrombosis in patients with severe
SARS-CoV-2 infection: a multicenter prospective cohort study.
Intensive Care Med 2020;46:1089–1098.
Copyright © 2020 by the American Thoracic Society
Sonographic B-Lines, Fluid Resuscitation, and
Hypoxemia in Malawian Patients with
Suspected Sepsis
To the Editor:
The optimal approach to fluid resuscitation for patients with
sepsis is uncertain. Data from sub-Saharan Africa have indicated
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potential for harm from aggressive treatment with intravenous fluids
(1, 2). Nevertheless, intravenous fluids remain an important
therapy, and strategies to optimize their use are urgently needed.
The role of lung ultrasonography for guiding fluid management
for patients with sepsis is undefined. Sonographic B-lines correlate
with measurements of extravascular lung water (3–5). Increased
extravascular lung water is associated with increased mortality in
sepsis (6–8). Lung ultrasonography has therefore been proposed as
a tool for assessing fluid tolerance in sepsis.
We recruited a cohort of 70 patients who presented to the
Queen Elizabeth Central Hospital in Blantyre, Malawi, with
suspected sepsis. The aims of the study were to estimate the effect of
intravenous fluid treatment on lung ultrasound findings and to
examine the relationship between lung ultrasound findings and the
development of hypoxemia. Some results were reported previously
in an abstract (9).
Methods
Participants were a convenience sample of adults over 18
years old who presented to the Queen Elizabeth Central
Hospital with suspected sepsis during weekdays, recruited
between 7 A.M. and 4 P.M. Suspected sepsis was defined as an
abnormal temperature measurement (>38.08C or ,36.08C) or
symptoms of fevers, chills, or rigors in the preceding week,
and evidence of hemodynamic instability (any one of the
following: tachycardia .120 beats/min; systolic blood
pressure ,90 mm Hg; or mean arterial pressure
,65 mm Hg). Written informed consent was provided by
participants or their surrogates. Prisoners were excluded, as
were any patients who had received more than 2 L intravenous
fluid prior to screening. Ethical approval was granted by the
Malawi College of Medicine (P.04/18/2385) and by the
University of California San Francisco (227029).
Eight-zone lung ultrasonographywas performed by an experienced
operator (R.J.W. or P.D.) using a Philips S4-1 Lumify phased array
transducer at enrollment, and again at 3, 6, 24, 48, and 72 hours. While
participants were supine, 4-second video clips were recorded at each
quadrant of the hemithorax for a total of eight clips per exam. Clips were
reviewed offline by an experienced reader (R.J.W.) at a later time, and a
B-line score was generated for each exam. B-lines are hyperechoic
artifacts that extend from the pleura through the depth of the image. The
maximal number of B-lines visualized in a single frame for each clip was
summed to generate a B-line score (10).
Table 1. Participant Characteristics
Variable n (%) or Median (IQR) (n= 70)
Physiologic variables
Sex, F 43 (61.4)
Age, yr 35 (26–47)
Heart rate, beats per min 130 (121–142)
Systolic blood pressure, mm Hg 99 (86–115)
Systolic blood pressure <90 mm Hg 24 (34.3)
Mean arterial pressure <65 mm Hg 15 (21.4)
Respiratory rate, breaths per min 28 (22–36)
Oxygen saturation while breathing room air, % 92 (86–96)
Oxygen saturation ,90% while breathing room air 30 (42.8)
Whole blood lactate, mmol/L 3.9 (2.6–7.2)
HIV-related variables
Unknown HIV serostatus at enrollment 2 (2.9)
Negative HIV serostatus tested within 6 mo 20 (28.6)
Known positive HIV serostatus 48 (68.6)
Time since HIV diagnosis, d (n=40) 537 (22–1,972)
On antiretroviral therapy at enrollment 41/48 (85.4)
Sepsis treatment variables
Cumulative amount of intravenous fluid given, ml
Prior to enrollment 0 (0–1,000)
By 3 h after enrollment 1,000 (200–1,450)
By 6 h after enrollment 1,000 (500–2,000)
By 24 h after enrollment 1,150 (1,000–2,000)
By 48 h after enrollment 1,900 (1,000–2,750)
By 72 h after enrollment 2,000 (1,000–3,000)
Cumulative number of participants who received empiric antibiotics (ceftriaxone, 2 g intravenous)
Prior to enrollment 21 (30.0)
By 3 h after enrollment 47 (67.1)
By 6 h after enrollment 60/66 (90.9)
By 24 h after enrollment 65/66 (98.5)
Number of participants treated with mechanical ventilation 0 (0)
Number of participants treated with a vasopressor infusion 1 (1.4)
Baseline sonographic B-line score* 5 (2–8)
In-hospital mortality 17 (24.3)
Definition of abbreviation: IQR= interquartile range.
*The sum of the number of B-lines observed in each of eight thoracic zones.
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Vital signs, including pulse oximetry on room air, were
measured at each time point. The volume of intravenous fluid given
between each time point was recorded. Clinical decisions regarding
intravenous fluids were made by each participant’s clinical team
strictly without input from research personnel.
To account for repeated measures, mixed-effects regression was
used to model the relationship between the volume of intravenous
fluid treatment and the B-line score at any time point, and between
the B-line score and oxygen saturation. To test whether the baseline B-
line score predicted impending hypoxemia, analysis was restricted to
the subset of participants who were normoxemic—had an oxygen
saturation of 90% or greater while breathing room air—at baseline.
Simple logistic regression was used to model the baseline B-line
score as the predictor and the development of hypoxemia—any
measurement of oxygen saturation ,90% while breathing room
air—in the first 72 hours of hospitalization as the outcome. To assess
the performance of the baseline B-line score for predicting
impending hypoxemia, the area under the receiver operating curve
was calculated, with 1,000 bootstrap replications to obtain bias-
corrected 95% confidence intervals (CIs).
Results
Clinical characteristics for the 70 participants enrolled in the
study from July 18, 2018, through October 26, 2018, are shown
in Table 1.
The volume of intravenous fluid treatment was significantly
associated with the number of B-lines detected. Within the first 72
hours of hospitalization, every additional liter of intravenous fluid
treatment was associated with approximately one additional B-line
(1.01; 95% CI, 0.59–1.43 P, 0.001).
The number of B-lines detected was significantly associated
with oxygen saturation. For every additional B-line detected, a
participant’s oxygen saturation was decreased by 0.24% (95% CI,
0.07–0.41; P= 0.005).
Among the 39 participants who were normoxemic on
presentation, the baseline B-line score predicted the development of
hypoxemia within 72 hours of enrollment. Every additional B-line
detected at baseline was associated with 1.5 (95% CI, 1.1–2.0;
P= 0.01) times the odds of developing hypoxemia within the
subsequent 72 hours. The area under the receiver operating
characteristic curve (Figure 1) was 0.86 (95% CI, 0.69–0.97). A
B-line score .5 was 86% sensitive and 72% specific for identifying
a patient who, though normoxemic at the time of baseline
examination, would develop hypoxemia within 72 hours.
Discussion
In this study, we found a significant association between the volume
of intravenous fluid received and the number of B-lines
subsequently detected with lung ultrasonography. The number of B-
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Figure 1. A receiver operating characteristic curve illustrating how the sonographic B-line score predicts future hypoxemia. The area under the receiver
operating characteristic curve is 0.86 (95% confidence interval, 0.69–0.97).
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measurement of oxygen saturation. Lastly, the baseline lung
ultrasound exam might identify normoxemic patients who are
at increased risk of developing hypoxemia within the first 72
hours of hospitalization. Because this is an observational study,
these findings suggest, but do not establish, a potential role for
using lung ultrasonography to assess fluid tolerance in patients
with sepsis.
An important strength of this study is that it was performed in a
hospital in Malawi, where there is a paucity of—and, perhaps, the
greatest need for—data on fluid resuscitation in patients with
suspected sepsis. A limitation of this study is the small sample size.
A further limitation of this study is that the ultrasound exams were
scored by a single experienced reader who had access to the full
data set and, thus, was not formally blinded to data on intravenous
fluid volume or oxygen saturation.
Despite these limitations, we believe the results of this study
attest to the relationship between intravenous fluid treatment,
sonographic B-lines, and clinical outcomes, such as impaired
oxygenation. Testing an ultrasound-guided fluid resuscitation
strategy in sepsis warrants further investigation. n
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Mycobacterium abscessus and Gastroesophageal
Reflux: An In Vitro Study
To the Editor:
Respiratory disorders such as idiopathic pulmonary fibrosis,
laryngeal dysfunction, and asthma are increasingly associated
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